International Drug Development Institute – IDDI

International Drug Development Institute – IDDI

IDDI is a therapy-focused clinical data services and high-level strategic consulting contract research organization, providing agile clinical trial services for pharmaceutical, biotechnology, and medical device/diagnostic companies.    

Visit Website


  • APAC
  • Europe
  • North America

Therapeutic Areas

  • Cardiovascular
  • CNS Diseases
  • Musculoskeletal
  • Oncology
  • Ophthalmology
  • Rare Disease

Founded in 1991 by Marc Buyse ScD, IDDI is a global privately-held company with offices in Ottignies-LLN, Belgium and Raleigh (NC) USA.


  • Clinical Development Strategy
  • Innovative Clinical Study Design
  • Advanced Biostatistics – IDMCs
  • Comprehensive Data Management
  • Integrated Technology: Randomization and Trial Supply Management (RTSM)
  • Electronic Data Capture (EDC) and medical coding
  • Regulatory Consultancy
  • Biomarker and IVD Validation


Partners are trained on the functionality of the Coder application, process optimization, and scope of Coder services. This Accreditation teaches Partners to integrate the medical coding solution with EDC studies and administer Coder segments. Coder Accreditation is dependent on the successful completion of the Rave EDC accreditation.
Partners are trained on the functionality of the electronic data capture (EDC) and clinical data management (CDM) system, process optimization exercises and scope of Medidata Rave services. This Accreditation teaches the staff to perform end user training, user and site administration, study build, reporting, outputs and amendment manager.